Welcome to the Library, where you'll find a selection of industry resources including eBooks, Whitepapers, Webinars, Survey Reports, Research Reports and more.
If you are interested in submitting items to the Library, please contact our advertising team
LIBRARY
The Basics of Biotech 101, 201 & 301
This 3-part webinar series is specifically geared toward the non-science professional who needs to better understand industry terminology, science, techniques and issues. This series provides an overview of the science and technology used to enable discovery and the processes scientists use to discover new therapeutics. Download now.
Global Clinical Trial Data Collection
Companies are losing clients and compromising their global clinical trials because the worldwide telephone numbers assigned to these trials are flawed. Participants and doctors calling to report critical trial data often cannot due to non-operational telephone numbers. To learn more visit our website http://www.fiercebiotech.com/offer/clinicaltrial_telephone.
Modernizing Pharmaceutical R&D with Metabolomics - Reducing Attrition with Better Models, Compounds, and Biomarkers
This webinar will convey the utility of metabolomics for developing or determining the most appropriate animal model for target/compound evaluation, providing a high-resolution assessment of compounds to add assurance and guidance in candidate selection, and elucidating sensitive and specific biomarkers of disease and response. Register today to tune into this live event.
How to raise medical device startup funding in a harsh investment climate
Investor consolidation and increased investor wariness have made funding for medical device and diagnostics ideas much harder to secure. Join us as we discuss what kinds of medical device and diagnostics startups are attracting venture funding and what investors are looking for now. Register Today!
Pharmaceutical Development for ADCs: Not as Simple as ABC
Formulation, process, and analytical development for ADCs is complex. Join our experts as we discuss ADC structure and function, the development process (including analytical methods, stability, and lyo cyle optimization) and parenteral product development. Register Today!
Too Big to Succeed: What's Next for Big Pharma?
The biopharmaceutical industry's largest companies have grown too large to offer shareholders a compelling return. L.E.K.'s analysis shows how pharma companies can address their most pressing challenges. Learn more
Mobile HTML5 For The Enterprise: The Optimum Path to Seamless and Secure Enterprise Mobility
The key factors when choosing HTML5 as the development platform for mobile. Download Now.
Single Use Technology: From Bioprocess Convenience to Drug-Development Driver
In order to accelerate the production of biological molecules, companies have been exploring disposable, single-use systems. Download this ebook to learn the impact and future use of single-use technologies, cost-saving opportunities, and challenges of implementing new drug development processes.
Clinical trials in Asia: Opening up to the world
The number of clinical trials carried out in Asia is rising. While talking about 'Asia' as a whole can be a bit of a generalization, the region has a number of advantantages for companies moving into clinical trials. This webinar will discuss quality assurance in overseas clinical trials and how to handle the regulatory maze. Watch Now.
FierceBiotech Special Report | Foundations Fuel Risky Biotech Ventures
Non-profits are taking larger roles in funding clinical trials and research. With their primary goal being finding cures, rather than financial gain, the influx of non-profit research donations may help accelerate cures and advanced research. Download now.
Pay HCPs...NOT Penalties
Watermark's Shade Solution: pay HCP, tracking, reporting, and managing yearend tax forms, and int'l. Find out more and download today!
Tablets for Trials: Will Mobile Tech Make Development More Efficient?
With the clinical trial model as flawed as it is, pharma companies are turning to mobile technology as a way to increase success rate and drive down costs. So, what, if anything, can tablets and smartphones do to improve drug development? Download now.
Opportunities and Challenges in Emerging Markets
Join as we discuss the commercial opportunities in emerging markets and the rise of the pharmaceutical industry in China and other countries. Importantly, learn what regulatory and reimbursement challenges present potential hurdles to succeeding in emerging markets. Watch Now!
Patient-Centric Drug Formulation Principles: Formulating Drugs for Children and the Elderly
How are drug developers and doctors tailoring prescriptions to patients? FierceBiotech outlines the principles and strategies for patient-centric drug development. Learn More.
The Boom in Rare-Disease Drug R&D
Big Pharma and a growing number of up-and-coming biotechs alike have focused their attention on developing new drugs for rare diseases. Join a panel of experts to discuss R&D strategies, patient communications and recruitment, and new regulatory changes which promise to shorten development timelines. Watch Now!
Conversations with World-Class Biotech Innovators
What elevates a researcher to the top of the industry? FierceBiotech profiled five prominent researchers and asked them how they garnered such success. Download for free today.
Drugmakers go mobile
With a steady stream of new mobile apps, pharma companies aim to catch up with their target audiences on a number of fronts. But what makes a winning mobile app in pharma? Join as we discuss how drugmakers have effectively raised their mobile games to achieve a variety of strategic objectives. Watch Now!
Special Report: China's Rise Drives Investment in Biotech Drugs
The Chinese government's devotion to biotech has sparked major expansion efforts by some of the country's leading pharmaceutical players, also making it fertile ground for venture capitalists in the U.S. Click here to download the complete report today.
Orphan Drug Differentiation
Join as we hear experts from orphan drug units explain how the commercial landscape of their field is changing and how orphan drug specialists have optimized patient access. Glean the latest insights on working with payers and reimbursement and get the pulse on the market and how competition brought key changes. Watch Today!
Discover Causal Connections. Faster.
The formation, maintenance and repair of epithelial barriers are of critical importance for whole body homeostasis. However the deregulation of these pathways gives rise to disease states such as fibrosis and carcinogenesis. Join us as we discuss Ingenuity's IPA, its newest features and how it is being used in research today. Register Today!
Special Report: Rare Disease and Orphan Disease Drug Development
Drug developers are devoting considerable resources to rare indications and adopting some clever science to bring those orphan diseases home. To read more about the challenges and opportunities associated with bringing drugs for rare diseases to market, click here to download the complete report today.
Sterile Manufacturing of Semi- Solids and Liquids
The role of sterility is a simple one—it is to protect people against infection and contamination. Vital steps and approaches in sterile manufacturing include employee training, process qualification and validation, processes and protocols for cleaning and decontamination, and methods to protect sterility and reduce contamination during processing. Click here to download this eBook today.
FierceBiotech Special Report: Armed Antibodies Readied for War on Cancer
For the drug developers looking to bring these products to market, ADCs represent the inevitable marriage of two sometimes hit-or-miss technologies, chemotherapy and antibodies, the next generation of anti-cancer compounds. In this Special Report FierceBiotech explores the potential and the challenges of the burgeoning field of ADCs.
The Right Fix: How Patient- Centric Data is Driving ROI and Revolutionizing the World of Pharmaceutical marketing
Advances in Anonymous Patient Level Data have empowered pharmaceutical marketers to refine their efforts to reach desired customers, accurately monitor the success of their campaigns, and ultimately generate greater ROI. Click here to download today.
Waiting for Guidelines, Will FDA Take the Reins of Laboratory-Developed Tests?
A new set of FDA regulations, covering a field the agency has chosen not to supervise in the past, could be a danger on both sides. As many labs, test developers, consultants and FDA lawyers have said, it's the kind of regulation that threatens to stifle innovation with more government red tape. Click here to download.
Supplying Global Clinical Trials: Keys to Avoiding Costly Delays
This FierceBiotech eBook provides expert analysis and industry insights to guide biopharma professionals that face the challenges of meeting strict timelines, selecting contractors and avoiding setbacks during the planning and execution of manufacturing partnerships for global clinical trials. Download Now.
Trends in Enterprise Content Management in BioPharma
This FierceBiotechIT eBook looks at how ECM has evolved, what the challenges to biopharma are, and how those challenges and obstacles are being met by a variety of ECM approaches. Download now.
Oral Drug Delivery Technologies: Tackling Clinical and Commercial Challenges
This FiercePharma eBook examines Big Pharma's need for technology to give new life to old drugs, and potentially deliver their next breakthrough medicines. This report covers some of the market opportunities, business strategies, and key innovations in the oral drug delivery field. Register Today!
Including China in Drug Development Programs: Opportunities & Challenges
China’s market growth makes it an attractive target for biopharmaceutical development. FierceBiotech takes an in-depth look at both the opportunities and challenges that come with drug development in the world’s most populous country. Download PDF now.
Academic and Pharma Partnerships: Tapping the Ivory Tower for the Next Blockbuster
This FiercePharma eBook examines the changing relationship between Big Pharma and academia. Through interviews with both academic and corporate insiders, we gather perspectives from each side and address potential stumbling blocks. While there are pitfalls along the way, there is also great potential if the path can be navigated safely. Download today.
Open R&D: Big Pharma Start Putting Collaboration Plans Into Practice
There's no part of the business more in need of metamorphosis than R&D, and no one more convinced of it than pharma's movers and shakers. To read more on this topic click here to download this eBook today.
